Pneumonia Testing Market - Top Companies and Manufacturers

  • Report ID: 4457
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Pneumonia Testing Landscape

    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • bioMérieux SA
    • INTEC
    • OpGen
    • BD (Becton, Dickinson, and Company)
    • Meridian Bioscience, Inc.
    • Luminex Corporation (DiaSorin S.p.A.)
    • F. Hoffmann-La Roche Ltd.

Browse Key Market Insights with Data Illustration:

In the News

  • bioMérieux, a global leader in invitro diagnostics, unveils that it has reached an agreement to procure Specific Diagnostics, a privately held American Company that has created a rapid antimicrobial susceptibility test (AST) system that provides phenotypic AST directly from positive blood cultures.

  • A corporation among DiaSorin (FTSE MIB: DIA) and B.R.A.H.M.S. GmbH, a division of Thermo Fisher Scientific, has been formed with the goal of developing and marketing the novel LIAISON B.R.A.H.M.S MR-proADM immunodiagnostic test. The test can assist in the detection of several serious illnesses, including sepsis, septic shock, lower respiratory infections, urinary tract infections, and kidney disease.


Author Credits:  Radhika Pawar


  • Report ID: 4457
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pneumonia testing is evaluated at USD 721.19 million.

The pneumonia testing market size was valued at USD 688.68 million in 2024 and is projected to exceed USD 1.43 billion by the end of 2037, expanding at over 5.9% CAGR during the forecast period i.e., between 2025-2037. Rising cases of COVID-19, Increasing incidence of hospital-acquired pneumonia (HAP), growing geriatric population, and advancement of POCT and nucleic acid detection tests will impel the market growth.

North America is anticipated to hold largest industry share by 2037, fueled by the rising prevalence of pneumonia in the region.

The major players in the market include Abbott, Quidel Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, INTEC, OpGen, BD (Becton, Dickinson, and Company), Meridian Bioscience, Inc., Luminex Corporation (DiaSorin S.p.A.), F. Hoffmann-La Roche Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample